theragenomics: biomarkers

thasso presents to you the overview table “theragenomic biomarkers” in context of their medications, indications, and pertinent FDA drug label sections (which may point to the affected patient groups).  The basis for this product is the list of accepted biomarkers as published by the FDA. Drugs are linked to the according drug labels accessible in Drugs@FDA.

  • Please note that in this table, the Active Pharmacological Ingredient (API) is listed; brand names of the marketed products may vary considerably, that is, trade names for APIs approved in or outside the US may differ, as may the names of generics, both within and outside the US. In case of doubt, searching for the API in the first place would be a good idea.
  • Please note also that you may download extended detailed version of the Table of Pharmacogenomic Biomarkers in Drug Labeling with Labeling Text, with complete PGX-related labelling text sections excerpted from the complete drug labels.

 

Last update: December 11, 2022

 

Table of Pharmacogenomic Biomarkers in Drug Labeling | FDA
 DrugTherapeutic Area*Biomarker†Labeling Sections
 AbacavirInfectious DiseasesHLA-BBoxed Warning, Dosage and Administration, Contraindications, Warnings and Precautions
 Abemaciclib (1)OncologyESR (Hormone Receptor)Indications and Usage, Adverse Reactions, Clinical Studies
 Abemaciclib (2)OncologyERBB2 (HER2)Indications and Usage, Adverse Reactions, Clinical Studies
 Abemaciclib (3)OncologyMKI67Indications and Usage, Dosage and Administration, Clinical Studies
 AbrocitinibDermatologyCYP2C19Dosage and Administration, Use in Specific Populations, Clinical Pharmacology
 Ado-Trastuzumab EmtansineOncologyERBB2 (HER2)Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology, Clinical Studies
 Aducanumab-avwaNeurologyAPOEWarnings and Precautions, Clinical Studies
 AfatinibOncologyEGFRIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 AlectinibOncologyALKIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology, Clinical Studies
 Alglucosidase AlfaInborn Errors of MetabolismGAAWarnings and Precautions
 AllopurinolOncologyHLA-BWarnings
 Alpelisib (1) OncologyERBB2 (HER2)Indication and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 Alpelisib (2)OncologyESR (Hormone Receptor)Indication and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 Alpelisib (3)OncologyPIK3CAIndication and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 AmifampridineNeurologyNAT2Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology
 Amifampridine PhosphateNeurologyNAT2Dosage and Administration, Use in Specific Populations, Clinical Pharmacology
 AmitriptylinePsychiatryCYP2D6Precautions
 Amivantamab-vmjwOncologyEGFRIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 AmoxapinePsychiatryCYP2D6Precautions
 AmphetaminePsychiatryCYP2D6Clinical Pharmacology
 AnakinraRheumatologyNLRP3Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 AnastrozoleOncologyESR, PGR (Hormone Receptor)Indications and Usage, Adverse Reactions, Drug Interactions, Clinical Studies
 Anifrolumab-fniaRheumatologyGene Signature (IFN)Clinical Pharmacology, Clinical Studies
 Arformoterol (1)PulmonaryUGT1A1Clinical Pharmacology
 Arformoterol (2)PulmonaryCYP2D6Clinical Pharmacology
 AripiprazolePsychiatryCYP2D6Dosage and Administration, Use in Specific Populations, Clinical Pharmacology
 Aripiprazole LauroxilPsychiatryCYP2D6Dosage and Administration, Use in Specific Populations, Clinical Pharmacology
 Arsenic TrioxideOncologyPML-RARAIndications and Usage, Clinical Studies
 Articaine and Epinephrine (1)AnesthesiologyG6PDWarnings and Precautions
 Articaine and Epinephrine (2)AnesthesiologyNonspecific (Congenital Methemoglobinemia)Warnings and Precautions
 AsciminibOncologyBCR-ABL1 (Philadelphia chromosome)Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies
 Atezolizumab (1)OncologyCD274 (PD-L1)Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology, Clinical Studies
 Atezolizumab (2)  OncologyGene Signature (T-effector)Clinical Studies
 Atezolizumab (3)OncologyEGFRIndications and Usage, Adverse Reactions, Clinical Studies
 Atezolizumab (4)OncologyALKIndications and Usage, Adverse Reactions, Clinical Studies
 Atezolizumab (5)OncologyBRAFIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 AtomoxetinePsychiatryCYP2D6Dosage and Administration, Warnings and Precautions, Adverse Reactions, Drug Interactions, Use in Specific Populations, Clinical Pharmacology
 Ascorbic Acid, PEG-3350, Potassium Chloride, Sodium Ascorbate, Sodium Chloride, and Sodium SulfateGastroenterologyG6PDWarnings and Precautions, Adverse Reactions
 Avapritinib (1)OncologyPDGFRAIndications and Usage, Dosage and Administration, Clinical Studies
 Avapritinib (2)OncologyKITClinical Studies
 Avatrombopag (1)HematologyF2 (Prothrombin)Warnings and Precautions
 Avatrombopag (2)HematologyF5 (Factor V Leiden)Warnings and Precautions
 Avatrombopag (3)HematologyPROCWarnings and Precautions
 Avatrombopag (4)HematologyPROS1Warnings and Precautions
 Avatrombopag (5)HematologySERPINC1 (Antithrombin III)Warnings and Precautions
 Avatrombopag (6)HematologyCYP2C9Clinical Pharmacology
 AvelumabOncologyCD274 (PD-L1)Clinical Studies
 Azacitidine (1)OncologyCBLClinical Studies
 Azacitidine (2)OncologyPTPN11Clinical Studies
 Azacitidine (3)OncologyRASClinical Studies
 Azathioprine (1)RheumatologyTPMTDosage and Administration,  Warnings, Precautions, Drug Interactions, Adverse Reactions, Clinical Pharmacology
 Azathioprine (2)RheumatologyNUDT15Dosage and Administration, Warnings, Precautions, Adverse Reactions, Clinical Pharmacology
 BelinostatOncologyUGT1A1Dosage and Administration, Clinical Pharmacology
 Belzutifan (1)OncologyCYP2C19Warnings and Precautions, Drug Interactions, Use in Specific Populations, Clinical Pharmacology
 Belzutifan (2)OncologyUGT2B17Warnings and Precautions, Drug Interactions, Use in Specific Populations, Clinical Pharmacology
 Belzutifan (3)OncologyVHLClinical Studies
 Binimetinib (1)OncologyBRAFIndications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Studies  
 Binimetinib (2)OncologyUGT1A1Clinical Pharmacology
 Blinatumomab (1)OncologyBCR-ABL1 (Philadelphia chromosome)Adverse Reactions, Clinical Studies
 Blinatumomab (2)OncologyCD19Indications and Usage
 BoceprevirInfectious DiseasesIFNL3 (IL28B)Clinical Pharmacology
 BosutinibOncologyBCR-ABL1 (Philadelphia chromosome)Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Studies
 Brentuximab Vedotin (1)OncologyALKClinical Studies
 Brentuximab Vedotin (2)OncologyTNFRSF8 (CD30)Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies
 BrexpiprazolePsychiatryCYP2D6Dosage and Administration, Use in Specific Populations, Clinical Pharmacology
 BrigatinibOncologyALKIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 BrivaracetamNeurologyCYP2C19Clinical Pharmacology
 Bupivacaine (1)AnesthesiologyG6PDWarnings
 Bupivacaine (2)AnesthesiologyNonspecific (Congenital Methemoglobinemia)Warnings
 BupropionPsychiatryCYP2D6Clinical Pharmacology
 BusulfanOncologyBCR-ABL1 (Philadelphia chromosome)Clinical Studies
 Cabotegravir and Rilpivirine (1)Infectious DiseasesHLA-BClinical Studies
 Cabotegravir and Rilpivirine (2)Infectious DiseasesUGT1A1Clinical Pharmacology
 CabozantinibOncologyRETClinical Studies
 CapmatinibOncologyMETIndications and Usage, Dosage and Administration, Clinical Studies
 CapecitabineOncologyDPYDWarnings and Precautions, Patient Counseling Information
 Carbamazepine (1)NeurologyHLA-BBoxed Warning, Warnings, Precautions
 Carbamazepine (2)NeurologyHLA-AWarnings
 Carglumic AcidInborn Errors of MetabolismNAGSIndications and Usage, Dosage and Administration, Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 CariprazinePsychiatryCYP2D6Clinical Pharmacology
 CarisoprodolRheumatologyCYP2C19Use in Specific Populations, Clinical Pharmacology
 CarvedilolCardiologyCYP2D6Drug Interactions, Clinical Pharmacology
 CasimersenNeurologyDMDIndications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Ceftriaxone (1)Infectious DiseasesG6PDWarnings
 Ceftriaxone (2)Infectious DiseasesNonspecific (Congenital Methemoglobinemia)Warnings
 CelecoxibRheumatologyCYP2C9Dosage and Administration, Use in Specific Populations, Clinical Pharmacology
 Cemiplimab-rwlc (1)OncologyALKIndications and Usage, Clinical Studies
 Cemiplimab-rwlc (2)OncologyCD274 (PD-L1)Indications and Usage, Dosage and Administration, Clinical Studies
 Cemiplimab-rwlc (3)OncologyEGFRIndications and Usage, Clinical Studies
 Cemiplimab-rwlc (4)OncologyROS1Indications and Usage, Clinical Studies
 CeritinibOncologyALKIndications and Usage, Dosage and Administration, Warning and Precautions, Adverse Reactions, Clinical Studies
 Cerliponase AlfaInborn Errors of MetabolismTPP1Indications and Usage, Use in Specific Populations, Clinical Studies
 Cetuximab (1)OncologyEGFRIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 Cetuximab (2)OncologyRASIndications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Studies
 Cetuximab (3)OncologyBRAFIndications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies
 CevimelineDentalCYP2D6Precautions
 Chloroprocaine (1)AnesthesiologyG6PDWarnings
 Chloroprocaine (2)AnesthesiologyNonspecific (Congenital Methemoglobinemia)Warnings
 ChloroquineInfectious DiseasesG6PDPrecautions, Adverse Reactions
 ChlorpropamideEndocrinologyG6PDPrecautions
 Cholic AcidInborn Errors of MetabolismAMACR, AKR1D1, CYP7A1, CYP27A1, DHCR7, HSD3B2 (Bile Acid Synthesis Disorders)Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Studies
 CisplatinOncologyTPMTAdverse Reactions
 Citalopram (1)PsychiatryCYP2C19Dosage and Administration, Warnings, Clinical Pharmacology
 Citalopram (2)PsychiatryCYP2D6Clinical Pharmacology
 ClobazamNeurologyCYP2C19Dosage and Administration, Use in Specific Populations, Clinical Pharmacology
 ClomipraminePsychiatryCYP2D6Precautions
 ClopidogrelCardiologyCYP2C19Boxed Warning, Warnings and Precautions, Clinical Pharmacology
 ClozapinePsychiatryCYP2D6Dosage and Administration, Use in Specific Populations, Clinical Pharmacology
 CobimetinibOncologyBRAFIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 CodeineAnesthesiologyCYP2D6Boxed Warning, Warnings and Precautions, Use in Specific Populations, Patient Counseling Information
 Crizanlizumab-tmcaHematologyHBBAdverse Reactions, Clinical Studies
 Crizotinib (1)OncologyALKIndications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Crizotinib (2)OncologyROS1Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies
 Dabrafenib (1)OncologyBRAFIndications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Dabrafenib (2)OncologyG6PDWarnings and Precautions, Adverse Reactions, Patient Counseling Information
 Dabrafenib (3)OncologyRASDosage and Administration, Warnings and Precautions
 DaclatasvirInfectious DiseasesIFNL3 (IL28B)Clinical Studies
 DacomitinibOncologyEGFRIndications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies
 Dapsone (1)DermatologyG6PDWarnings and Precautions, Use in Specific Populations, Patient Counseling Information
 Dapsone (2)DermatologyNonspecific (Congenital Methemoglobinemia)Warnings and Precautions, Adverse Reactions, Patient Counseling Information
 Dapsone (3)Infectious DiseasesG6PDPrecautions, Adverse Reactions, Overdosage
 DarifenacinUrologyCYP2D6Clinical Pharmacology
 Dasabuvir, Ombitasvir, Paritaprevir, and RitonavirInfectious DiseasesIFNL3 (IL28B)Clinical Studies
 DasatinibOncologyBCR-ABL1 (Philadelphia chromosome)Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Studies
 Denileukin DiftitoxOncologyIL2RA (CD25 antigen)Indications and Usage, Clinical Studies
 DesipraminePsychiatryCYP2D6Precautions
 DesfluraneAnesthesiologyNonspecific (Genetic Susceptibility to Malignant Hyperthermia)Contraindications
 DesvenlafaxinePsychiatryCYP2D6Clinical Pharmacology
 DeutetrabenazineNeurologyCYP2D6Dosage and Administration, Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology
 DexlansoprazoleGastroenterologyCYP2C19Drug Interactions, Clinical Pharmacology
 Dextromethorphan and QuinidineNeurologyCYP2D6Warnings and Precautions, Clinical Pharmacology
 DiazepamNeurologyCYP2C19Clinical Pharmacology
 DinutuximabOncologyMYCNClinical Studies
 DocetaxelOncologyESR, PGR (Hormone Receptor)Clinical Studies
 DolutegravirInfectious DiseasesUGT1A1Clinical Pharmacology
 DonepezilNeurologyCYP2D6Clinical Pharmacology
 Dostarlimab-gxlyOncologyMismatch RepairIndication and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 Doxepin (1)PsychiatryCYP2D6Clinical Pharmacology
 Doxepin (2)PsychiatryCYP2C19Clinical Pharmacology
 DronabinolGastroenterologyCYP2C9Use in Specific Populations, Clinical Pharmacology
 Drospirenone and Ethinyl EstradiolGynecologyCYP2C19Clinical Pharmacology
 DuloxetinePsychiatryCYP2D6Drug Interactions
 DurvalumabOncologyCD274 (PD-L1)Clinical Pharmacology, Clinical Studies
 DuvelisibOncologyChromosome 17pClinical Studies
 Eculizumab (1)NeurologyACHRIndications and Usage, Clinical Studies
 Eculizumab (2)NeurologyAQP4Indications and Usage, Clinical Studies
 EfavirenzInfectious DiseasesCYP2B6Clinical Pharmacology
 Efgartigimod Alfa-fcabNeurologyACHRIndications and Usage, Clinical Pharmacology, Clinical Studies
 ElagolixGynecologySLCO1B1Clinical Pharmacology
 Elbasvir and GrazoprevirInfectious DiseasesIFNL3 (IL28B)Clinical Studies
 Elexacaftor, Ivacaftor, and TezacaftorPulmonaryCFTRIndications and Usage, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 EliglustatInborn Errors of MetabolismCYP2D6Indications and Usage, Dosage and Administration, Contraindications, Warnings and Precautions, Drug Interactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 ElosulfaseInborn Errors of MetabolismGALNSIndications and Usage, Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Eltrombopag (1)HematologyF5 (Factor V Leiden)Warnings and Precautions
 Eltrombopag (2)HematologySERPINC1 (Antithrombin III)Warnings and Precautions
 Eltrombopag (3)HematologyChromosome 7Adverse Reactions
 Eltrombopag (4)HematologyChromosome 13Adverse Reactions
 Emapalumab-lzsgHematologyPRF1, RAB27A, SH2D1A, STXBP2, STX11, UNC13D, XIAP (Hemophagocytic Lymphohistiocytosis)Clinical Studies
 EnasidenibOncologyIDH2Indications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical Studies
 Encorafenib (1)OncologyBRAFIndications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Encorafenib (2)OncologyRASDosage and Administration, Warnings and Precautions, Clinical Studies  
 Enfortumab Vedotin-ejfvOncologyNECTIN4Clinical Studies
 Entrectinib (1)OncologyROS1Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Entrectinib (2)OncologyNTRKIndications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Erdafitinib (1)OncologyFGFRIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies, Patient Counseling Information
 Erdafitinib (2) OncologyCYP2C9Use in Specific Populations, Clinical Pharmacology
 Eribulin (1)OncologyERBB2 (HER2)Clinical Studies
 Eribulin (2)OncologyESR, PGR (Hormone Receptor)Clinical Studies
 ErlotinibOncologyEGFRIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 Erythromycin and SulfisoxazoleInfectious DiseasesG6PDPrecautions
 Escitalopram (1)PsychiatryCYP2D6Drug Interactions
 Escitalopram (2)PsychiatryCYP2C19Adverse Reactions
 EsomeprazoleGastroenterologyCYP2C19Drug Interactions, Clinical Pharmacology
 Estradiol and Progesterone (1)GynecologyPROCContraindications
 Estradiol and Progesterone (2)GynecologyPROS1Contraindications
 Estradiol and Progesterone (3)GynecologySERPINC1 (Antithrombin III)Contraindications
 Estradiol ValerateGynecologyESR, PGR (Hormone Receptor)Warnings
 EteplirsenNeurologyDMDIndications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies
 Everolimus (1)OncologyERBB2 (HER2)Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Everolimus (2)OncologyESR (Hormone Receptor)Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Evinacumab-dgnb (1)EndocrinologyLDLRClinical Studies
 Evinacumab-dgnb (2)Endocrinology    Nonspecific (Homozygous Familial Hypercholesterolemia)Indication and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 ExemestaneOncologyESR, PGR (Hormone Receptor)Indications and Usage, Dosage and Administration, Clinical Studies
 Fam-Trastuzumab Deruxtecan-nxkiOncologyERBB2 (HER2)Indications and Usage, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 FesoterodineUrologyCYP2D6Drug Interactions, Clinical Pharmacology
 Fosphenytoin (1)NeurologyCYP2C9Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology
 Fosphenytoin (2) NeurologyHLA-BWarnings and Precautions
 Flibanserin (1)GynecologyCYP2C9Clinical Pharmacology
 Flibanserin (2)GynecologyCYP2C19Adverse Reactions, Use in Specific Populations, Clinical Pharmacology
 Flibanserin (3)GynecologyCYP2D6Clinical Pharmacology
 Fluorouracil (1)DermatologyDPYDContraindications, Warnings
 Fluorouracil (2)OncologyDPYDWarnings and Precautions, Patient Counseling Information
 FluoxetinePsychiatryCYP2D6Precautions, Clinical Pharmacology
 FlurbiprofenRheumatologyCYP2C9Clinical Pharmacology
 FlutamideOncologyG6PDWarnings
 FluvoxaminePsychiatryCYP2D6Drug Interactions
 Formoterol (1)PulmonaryCYP2D6Clinical Pharmacology
 Formoterol (2)PulmonaryCYP2C19Clinical Pharmacology
 FosdenopterinNeurologyMOCS1Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Fulvestrant (1)OncologyERBB2 (HER2)Indications and Usage, Adverse Reactions, Clinical Studies
 Fulvestrant (2)OncologyESR, PGR (Hormone Receptor)Indications and Usage, Adverse Reactions, Clinical Pharmacology, Clinical Studies
 GalantamineNeurologyCYP2D6Clinical Pharmacology
 GanaxoloneNeurologyCDKL5Indications and Usage, Clinical Studies
 Gefitinib (1)OncologyEGFRIndications and Usage, Dosage and Administration, Clinical Studies
 Gefitinib (2)OncologyCYP2D6Clinical Pharmacology
 Gemtuzumab OzogamicinOnoclogyCD33Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 GilteritinibOncologyFLT3Indications and Usage, Dosage and Administration, Clinical Studies
 GivosiranGastroenterologyCPOX, HMBS, PPOX (Acute Hepatic Porphyria)Clinical Studies
 GlimepirideEndocrinologyG6PDWarnings and Precautions, Adverse Reactions
 GlipizideEndocrinologyG6PDPrecautions
 GlyburideEndocrinologyG6PDPrecautions
 Glycerol Phenylbutyrate (1)Inborn Errors of MetabolismASS1, CPS1, OTC (Urea Cycle Disorders)Indications and Usage, Adverse Reactions, Clinical Studies
 Glycerol Phenylbutyrate (2)Inborn Errors of MetabolismNAGSIndications and Usage
 GolodirsenNeurologyDMDIndications and Usage, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 GoserelinOncologyESR, PGR (Hormone Receptor)Indications and Usage, Clinical Studies
 HydralazineCardiologyNonspecific (NAT)Clinical Pharmacology
 HydroxychloroquineInfectious DiseasesG6PDWarnings and Precautions, Adverse Reactions
 Ibrutinib (1)OncologyChromosome 17pIndications and Usage, Clinical Studies
 Ibrutinib (2)OncologyChromosome 11qClinical Studies
 Ibrutinib (3)OncologyMYD88Clinical Studies
 IloperidonePsychiatryCYP2D6Dosage and Administration, Warnings and Precautions, Drug Interactions, Clinical Pharmacology
 Imatinib (1)OncologyKITIndications and Usage, Dosage and Administration, Clinical Studies
 Imatinib (2)OncologyBCR-ABL1 (Philadelphia chromosome)Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Imatinib (3)OncologyPDGFRBIndications and Usage, Dosage and Administration, Clinical Studies
 Imatinib (4)OncologyFIP1L1-PDGFRAIndications and Usage, Dosage and Administration, Clinical Studies
 ImipraminePsychiatryCYP2D6Precautions
 InclisiranEndocrinology  Nonspecific (Heterozygous Familial Hypercholesterolemia)Indications and Usage, Clinical Studies
 IndacaterolPulmonaryUGT1A1Clinical Pharmacology
 Inebilizumab-cdonNeurologyAQP4Indications and Usage, Clinical Studies
 InfigratinibOncologyFGFR2Indications and Usage, Dosage and Administration, Clinical Studies
 InotersenNeurologyTTRAdverse Reactions, Clinical Pharmacology
 Inotuzumab OzogamicinOncologyBCR-ABL1 (Philadelphia chromosome)Clinical Studies
 Ipilimumab (1)OncologyHLA-AClinical Studies
 Ipilimumab (2)OncologyMicrosatellite Instability, Mismatch RepairIndications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Studies
 Ipilimumab (3)OncologyCD274 (PD-L1)Indications and Usage, Dosage and Administration, Use in Specific Populations, Clinical Studies
 Ipilimumab (4)OncologyALKIndications and Usage, Adverse Reactions, Clinical Studies
 Ipilimumab (5)OncologyEGFRIndications and Usage, Adverse Reactions, Clinical Studies
 IrinotecanOncologyUGT1A1Dosage and Administration, Warnings and Precautions, Clinical Pharmacology
 Isatuximab- irfc (1)OncologyChromosome 17pClinical Studies
 Isatuximab- irfc (2)OncologyChromosome 4p;14qClinical Studies
 Isatuximab- irfc (3)OncologyChromosome 14q;16qClinical Studies
 IsofluraneAnesthesiologyNonspecific (Genetic Susceptibility to Malignant Hyperthermia)Contraindications
 Isoniazid, Pyrazinamide, and RifampinInfectious DiseasesNonspecific (NAT)Clinical Pharmacology
 Isosorbide DinitrateCardiologyCYB5ROverdosage
 Isosorbide MononitrateCardiologyCYB5ROverdosage
 IvacaftorPulmonaryCFTRIndications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Ivacaftor and LumacaftorPulmonaryCFTRIndications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies
 Ivacaftor and TezacaftorPulmonaryCFTRIndications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 IvosidenibOncologyIDH1Indications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical Studies
 Ixabepilone (1)OncologyERBB2 (HER2)Clinical Studies
 Ixabepilone (2)OncologyESR, PGR (Hormone Receptor)Clinical Studies
 LacosamideNeurologyCYP2C19Clinical Pharmacology
 LansoprazoleGastroenterologyCYP2C19Drug Interactions, Clinical Pharmacology
 Lapatinib (1)OncologyERBB2 (HER2)Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies
 Lapatinib (2)OncologyESR, PGR (Hormone Receptor)Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies
 Lapatinib (3)OncologyHLA-DQA1Clinical Pharmacology
 Lapatinib (4)OncologyHLA-DRB1Clinical Pharmacology
 LarotrectinibOncologyNTRKIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 Ledipasvir and SofosbuvirInfectious DiseasesIFNL3 (IL28B)Clinical Studies
 LenalidomideHematologyChromosome 5qBoxed Warning, Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies
 LenvatinibOncologyMicrosatellite Instability, Mismatch RepairIndications and Usage, Adverse Reactions, Clinical Studies
 LesinuradRheumatologyCYP2C9Drug Interactions, Clinical Pharmacology
 LetrozoleOncologyESR, PGR (Hormone Receptor)Indications and Usage, Adverse Reactions, Clinical Studies
 Lidocaine and Prilocaine (1)AnesthesiologyNonspecific (Congenital Methemoglobinemia)Warnings and Precautions
 Lidocaine and Prilocaine (2)AnesthesiologyG6PDWarnings and Precautions, Clinical Pharmacology
 Lidocaine and Tetracaine (1)AnesthesiologyG6PDWarnings and Precautions
 Lidocaine and Tetracaine (2)AnesthesiologyNonspecific (Congenital Methemoglobinemia)Warnings and Precautions
 LofexidineAnesthesiologyCYP2D6Use in Specific Populations
 LomitapideEndocrinologyNonspecific (Homozygous Familial Hypercholesterolemia)Indications and Usage, Warnings and Precautions, Adverse Reactions, Clinical Studies
 Lonafarnib (1)Inborn Errors of MetabolismLMNAIndications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies
 Lonafarnib (2)Inborn Errors of MetabolismZMPSTE24Indications and Usage, Use in Specific Populations
 Lorlatinib (1)OncologyALKIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 Lorlatinib (2)OncologyROS1Adverse Reactions
 LumasiranUrologyAGXTIndications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Luspatercept–aamtHematologyHBBClinical Studies
 Lusutrombopag (1)HematologyF2 (Prothrombin)Warnings and Precautions
 Lusutrombopag (2)HematologyF5 (Factor V Leiden)Warnings and Precautions
 Lusutrombopag (3)HematologyPROCWarnings and Precautions
 Lusutrombopag (4)HematologyPROS1Warnings and Precautions
 Lusutrombopag (5)HematologySERPINC1 (Antithrombin III)Warnings and Precautions
 Lutetium Lu 177 DotatateOncologySSTR Indications and Usage, Adverse Reactions, Clinical Pharmacology, Clinical Studies
 Lutetium Lu 177 Vipivotide TetraxetanOncologyFOLH1 (PSMA)Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 MafenideInfectious DiseasesG6PDWarnings, Adverse Reactions
 MaralixibatGastroenterologyJAG1Clinical Studies
 Margetuximab-cmkb (1)OncologyERBB2 (HER2)Indications and Usage, Adverse Reactions, Clinical Pharmacology, Clinical Studies
 Margetuximab-cmkb (2)OncologyFCGR2A (CD32A)Clinical Pharmacology
 Margetuximab-cmkb (3)OncologyFCGR2B (CD32B)Clinical Pharmacology
 Margetuximab-cmkb (4)OncologyFCGR3A (CD16A)Clinical Pharmacology
 MavacamtenCardiologyCYP2C19Dosage and Administration, Clinical Pharmacology
 MeclizineNeurologyCYP2D6Warnings and Precautions
 MeloxicamAnesthesiologyCYP2C9Use in Specific Populations, Clinical Pharmacology
 Mepivacaine (1)AnesthesiologyG6PDWarnings
 Mepivacaine (2)AnesthesiologyNonspecific (Congenital Methemoglobinemia)Warnings
 Mercaptopurine (1)OncologyTPMTDosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Pharmacology
 Mercaptopurine (2)OncologyNUDT15Dosage and Administration, Warnings and Precautions, Clinical Pharmacology
 Methylene BlueHematologyG6PDContraindications, Warnings and Precautions
 Metoclopramide (1)GastroenterologyCYB5RUse in Specific Populations
 Metoclopramide (2)GastroenterologyG6PDUse in Specific Populations, Overdosage
 Metoclopramide (3)GastroenterologyCYP2D6Dosage and Administration, Use in Specific Populations, Clinical Pharmacology
 MetoprololCardiologyCYP2D6Clinical Pharmacology
 MetreleptinEndocrinologyLEPContraindications
 Midostaurin (1)OncologyFLT3Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 Midostaurin (2)OncologyNPM1Clinical Studies
 Midostaurin (3)OncologyKITClinical Studies
 MigalastatInborn Errors of MetabolismGLAIndications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical Studies
 MirabegronUrologyCYP2D6Clinical Pharmacology
 MitapivatHematologyPKLRClinical Studies
 MivacuriumAnesthesiologyBCHEWarnings, Precautions, Clinical Pharmacology
 MobocertinibOncologyEGFRIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 ModafinilPsychiatryCYP2D6Clinical Pharmacology
 Mycophenolic AcidTransplantationHPRT1Warnings and Precautions
 Nalidixic AcidInfectious DiseasesG6PDPrecautions, Adverse Reactions
 NateglinideEndocrinologyCYP2C9Drug Interactions
 NebivololCardiologyCYP2D6Dosage and Administration, Clinical Pharmacology
 NefazodonePsychiatryCYP2D6Precautions
 Neratinib (1)OncologyERBB2 (HER2)Indications and Usage, Adverse Reactions, Clinical Studies
 Neratinib (2)OncologyESR, PGR (Hormone Receptor)Clinical Studies
 Nilotinib (1)OncologyBCR-ABL1 (Philadelphia chromosome)Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Nilotinib (2)OncologyUGT1A1Clinical Pharmacology
 NiraparibOncologyBRCA, Genomic Instability (Homologous Recombination Deficiency)Indication and Usage, Dosage and Administration, Clinical Studies
 NitrofurantoinInfectious DiseasesG6PDWarnings, Adverse Reactions
 Nivolumab (1)OncologyBRAFAdverse Reactions, Clinical Studies
 Nivolumab (2)OncologyCD274 (PD-L1)Indications and Usage, Dosage and Administration, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Nivolumab (3)OncologyMicrosatellite Instability, Mismatch RepairIndications and Usage, Clinical Studies
 Nivolumab (4)OncologyEGFRIndications and Usage, Adverse Reactions, Clinical Studies
 Nivolumab (5)OncologyALKIndications and Usage, Adverse Reactions, Clinical Studies
 Nivolumab (6)OncologyERBB2 (HER2)Adverse Reactions, Clinical Studies
 Nivolumab and Relatlimab-rmbw (1)OncologyBRAFClinical Studies
 Nivolumab and Relatlimab-rmbw (2)OncologyCD274 (PD-L1)Clinical Studies
 Nivolumab and Relatlimab-rmbw (3)OncologyLAG3Clinical Studies
 NortriptylinePsychiatryCYP2D6Precautions
 NusinersenNeurologySMN2Clinical Pharmacology, Clinical Studies
 ObinutuzumabOncologyMS4A1 (CD20 antigen)Clinical Studies
 OdevixibatGastroenterologyABCB11Indications and Usage, Clinical Studies
 Olaparib (1)OncologyBRCAIndications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Studies
 Olaparib (2)OncologyERBB2 (HER2)Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 Olaparib (3)OncologyESR, PGR (Hormone Receptor)Indications and Usage, Clinical Studies
 Olaparib (4)OncologyBRCA, Genomic Instability (Homologous Recombination Deficiency)Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 Olaparib (5)OncologyHomologous Recombination RepairIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 Olaparib (6)OncologyPPP2R2AClinical Studies
 OlaratumabOncologyPDGFRAClinical Studies
 OliceridineAnesthesiologyCYP2D6Warnings and Precautions, Drug Interactions, Use in Specific Populations, Clinical Pharmacology
 OmacetaxineOncologyBCR-ABL1 (Philadelphia chromosome)Clinical Studies
 Ombitasvir, Paritaprevir, and RitonavirInfectious DiseasesIFNL3 (IL28B)Clinical Studies
 OmeprazoleGastroenterologyCYP2C19Drug Interactions, Clinical Pharmacology
 Oxymetazoline and Tetracaine (1)AnesthesiologyG6PDWarnings and Precautions
 Oxymetazoline and Tetracaine (2)AnesthesiologyNonspecific (Congenital Methemoglobinemia)Warnings and Precautions
 OndansetronGastroenterologyCYP2D6Clinical Pharmacology
 OsimertinibOncologyEGFRIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 Ospemifene (1)GynecologyCYP2C9Clinical Pharmacology
 Ospemifene (2)GynecologyCYP2B6Clinical Pharmacology
 OxcarbazepineNeurologyHLA-BWarnings and Precautions
 Palbociclib (1)OncologyESR (Hormone Receptor)Indications and Usage, Adverse Reactions, Clinical Studies
 Palbociclib (2)OncologyERBB2 (HER2)Indications and Usage, Adverse Reactions, Clinical Studies
 PaliperidonePsychiatryCYP2D6Clinical Pharmacology
 PalonosetronGastroenterologyCYP2D6Clinical Pharmacology
 Panitumumab (1)OncologyEGFRAdverse Reactions, Clinical Pharmacology, Clinical Studies
 Panitumumab (2)OncologyRASIndications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Studies
 PantoprazoleGastroenterologyCYP2C19Clinical Pharmacology
 Parathyroid HormoneInborn Errors of MetabolismCASRIndications and Usage, Clinical Studies
 ParoxetinePsychiatryCYP2D6Drug Interactions, Clinical Pharmacology
 PatisiranNeurologyTTRAdverse Reactions, Clinical Pharmacology, Clinical Studies
 Pazopanib (1)OncologyUGT1A1Clinical Pharmacology
 Pazopanib (2)OncologyHLA-BClinical Pharmacology
 Peginterferon Alfa-2bInfectious DiseasesIFNL3 (IL28B)Clinical Pharmacology
 PegloticaseRheumatologyG6PDBoxed Warning, Contraindications, Warnings and Precautions, Patient Counseling Information
 Pembrolizumab (1)OncologyBRAFAdverse Reactions, Clinical Studies
 Pembrolizumab (2)OncologyCD274 (PD-L1)Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies
 Pembrolizumab (3)OncologyMicrosatellite Instability, Mismatch RepairIndications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies  
 Pembrolizumab (4)OncologyEGFRIndications and Usage, Adverse Reactions, Clinical Studies
 Pembrolizumab (5)OncologyALKIndications and Usage, Adverse Reactions, Clinical Studies
 Pembrolizumab (6)OncologyTumor Mutational BurdenIndications and Usage, Dosage and Administration, Clinical Studies
 Pembrolizumab (7)OncologyERBB2 (HER2)Indications and Usage, Adverse Reactions, Clinical Studies
 PemigatinibOncologyFGFR2Indication and Usage, Dosage and Administration, Clinical Studies
 PerphenazinePsychiatryCYP2D6Precautions, Clinical Pharmacology
 Pertuzumab (1)OncologyERBB2 (HER2)Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Pharmacology, Clinical Studies
 Pertuzumab (2)OncologyESR, PGR (Hormone Receptor)Clinical Studies
 Phenytoin (1)NeurologyCYP2C9Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology
 Phenytoin (2)NeurologyCYP2C19Clinical Pharmacology
 Phenytoin (3)NeurologyHLA-BWarnings and Precautions
 PimozidePsychiatryCYP2D6Dosage and Administration, Precautions
 PiroxicamRheumatologyCYP2C9Clinical Pharmacology
 PitolisantPsychiatryCYP2D6Dosage and Administration, Use in Specific Populations, Clinical Pharmacology
 PonatinibOncologyBCR-ABL1 (Philadelphia chromosome)Indications and Usage, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Studies
 PralsetinibOncologyCCDC6-RET, KIF5B-RET,  RETIndications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Prasugrel (1)CardiologyCYP2C19Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Prasugrel (2)CardiologyCYP2C9Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Prasugrel (3)CardiologyCYP3A5Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Prasugrel (4)CardiologyCYP2B6Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Primaquine (1)Infectious DiseasesG6PDContraindications, Warnings, Precautions, Adverse Reactions, Overdosage
 Primaquine (2) Infectious DiseasesCYB5RPrecautions, Adverse Reactions
 ProbenecidRheumatologyG6PDAdverse Reactions
 ProcainamideCardiologyNonspecific (NAT)Adverse Reactions, Clinical Pharmacology
 PropafenoneCardiologyCYP2D6Dosage and Administration, Warnings and Precautions, Drug Interactions, Clinical Pharmacology
 PropranololCardiologyCYP2D6Clinical Pharmacology
 ProtriptylinePsychiatryCYP2D6Precautions
 QuinidineCardiologyCYP2D6Precautions
 Quinine Sulfate (1)Infectious DiseasesG6PDWarnings and Precautions
 Quinine Sulfate (2)Infectious DiseasesCYP2D6Drug Interactions
 RabeprazoleGastroenterologyCYP2C19Drug Interactions, Clinical Pharmacology
 RaloxifeneOncologyESR (Hormone Receptor)Clinical Studies
 RaltegravirInfectious DiseasesUGT1A1Clinical Pharmacology
 Ramucirumab (1)OncologyEGFRIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 Ramucirumab (2)OncologyRASClinical Studies
 Rasburicase (1)OncologyG6PDBoxed Warning, Contraindications, Warnings and Precautions
 Rasburicase (2)OncologyCYB5RBoxed Warning, Contraindications, Warnings and Precautions
 Ravulizumab-cwvzNeurologyACHRIndications and Usage, Clinical Studies
 RegorafenibOncologyRASIndications and Usage, Clinical Studies
 Ribociclib (1)OncologyESR, PGR (Hormone Receptor)Indications and Usage, Adverse Reactions, Clinical Studies
 Ribociclib (2)OncologyERBB2 (HER2)Indications and Usage, Adverse Reactions, Clinical Studies
 RimegepantNeurologyCYP2C9Clinical Pharmacology
 RisdiplamNeurologySMN1, SMN2Clinical Studies
 RisperidonePsychiatryCYP2D6Clinical Pharmacology
 RituximabOncologyMS4A1 (CD20 antigen)Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies
 RivaroxabanCardiologyF5 (Factor V Leiden)Clinical Studies
 Ropeginterferon Alfa-2b-njftHematologyJAK2Clinical Pharmacology, Clinical Studies
 Ropivacaine (1)AnesthesiologyG6PDWarnings
 Ropivacaine (2)AnesthesiologyNonspecific (Congenital Methemoglobinemia)Warnings
 RosuvastatinEndocrinologySLCO1B1Clinical Pharmacology
 Rucaparib (1)OncologyBRCAIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 Rucaparib (2)OncologyCYP2D6Clinical Pharmacology
 Rucaparib (3)OncologyCYP1A2Clinical Pharmacology
 Rucaparib (4)OncologyBRCA, Loss of Heterozygosity (Homologous Recombination Deficiency)Warnings and Precautions, Adverse Reactions, Clinical Studies
 Sacituzumab Govitecan-hziyOncologyUGT1A1Warnings and Precautions, Clinical Pharmacology
 SacrosidaseInborn Errors of MetabolismSI  (Congenital Sucrase-Isomaltase Deficiency)Indications and Usage, Adverse Reactions, Clinical Pharmacology
 Satralizumab-mwgeNeurologyAQP4Indications and Usage, Adverse Reactions, Clinical Studies
 SelpercatinibOncologyRETIndications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies
 Setmelanotide (1)EndocrinologyLEPRIndications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies
 Setmelanotide (2)EndocrinologyPCSK1Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies
 Setmelanotide (3)EndocrinologyPOMCIndications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies
 SevofluraneAnesthesiologyRYR1Warnings
 SimeprevirInfectious DiseasesIFNL3 (IL28B)Clinical Pharmacology, Clinical Studies
 SiponimodNeurologyCYP2C9Dosage and Administration, Contraindications, Drug Interactions, Use in Specific Populations, Clinical Pharmacology
 Sodium Nitrite (1)ToxicologyG6PDWarnings and Precautions
 Sodium Nitrite (2)ToxicologyNonspecific (Congenital Methemoglobinemia)Boxed Warning, Warnings and Precautions
 Sodium OxybateNeurologyALDH5A1 (Succinic Semialdehyde Dehydrogenase Deficiency)Contraindications
 Sodium PhenylbutyrateInborn Errors of MetabolismASS1, CPS1, OTC (Urea Cycle Disorders)Indications and Usage, Dosage and Administration
 SofosbuvirInfectious DiseasesIFNL3 (IL28B)Clinical Studies
 Sofosbuvir and VelpatasvirInfectious DiseasesIFNL3 (IL28B)Clinical Studies
 Sofosbuvir, Velpatasvir, and VoxilaprevirInfectious DiseasesIFNL3 (IL28B)Clinical Studies
 SotorasibOncologyKRASIndication and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology, Clinical Studies
 SuccimerHematologyG6PDClinical Pharmacology
 Succinylcholine (1)AnesthesiologyBCHEWarnings, Precautions
 Succinylcholine (2)AnesthesiologyNonspecific (Genetic Susceptibility to Malignant Hyperthermia)Boxed Warning, Contraindications, Warnings, Precautions, Adverse Reactions
 SulfadiazineInfectious DiseasesG6PDWarnings
 Sulfamethoxazole and Trimethoprim (1)Infectious DiseasesG6PDPrecautions
 Sulfamethoxazole and Trimethoprim (2)Infectious DiseasesNonspecific (NAT)Precautions
 Sulfasalazine (1)GastroenterologyG6PDPrecautions
 Sulfasalazine (2)GastroenterologyNonspecific (NAT)Clinical Pharmacology
 Synthetic Conjugated Estrogens, A (1)GynecologyPROCContraindications
 Synthetic Conjugated Estrogens, A (2)GynecologyPROS1Contraindications
 Synthetic Conjugated Estrogens, A (3)GynecologySERPINC1 (Antithrombin III)Contraindications
 TafamidisCardiologyTTRClinical Pharmacology, Clinical Studies
 TafenoquineInfectious DiseasesG6PDDosage and Administration, Contraindications, Warnings and Precautions, Use in Specific Populations, Patient Counseling Information
 Talazoparib (1)OncologyBRCAIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies
 Talazoparib (2)OncologyERBB2 (HER2)Indications and Usage, Adverse Reactions, Clinical Studies
 Tamoxifen (1)OncologyESR, PGR (Hormone Receptor)Indications and Usage, Adverse Reactions, Clinical Pharmacology, Clinical Studies
 Tamoxifen (2)OncologyF5 (Factor V Leiden)Warnings and Precautions
 Tamoxifen (3)OncologyF2 (Prothrombin)Warnings and Precautions
 Tamoxifen (4)OncologyCYP2D6Clinical Pharmacology
 TamsulosinUrologyCYP2D6Warnings and Precautions, Adverse Interactions, Clinical Pharmacology
 Tebentafusp-tebnOncologyHLA-AIndications and Usage, Dosage and Administration, Clinical Studies
 TelaprevirInfectious DiseasesIFNL3 (IL28B)Clinical Pharmacology, Clinical Studies
 Tepotinib (1)OncologyALKClinical Studies
 Tepotinib (2)OncologyEGFRClinical Studies
 Tepotinib (3)OncologyMETIndications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies
 TetrabenazineNeurologyCYP2D6Dosage and Administration, Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology
 Thioguanine (1)OncologyTPMTDosage and Administration, Warnings, Precautions, Clinical Pharmacology
 Thioguanine (2)OncologyNUDT15Dosage and Administration, Warnings, Precautions, Clinical Pharmacology
 Thioridazine PsychiatryCYP2D6Contraindications, Warnings, Precautions
 TicagrelorCardiologyCYP2C19Clinical Pharmacology
 Tipiracil and Trifluridine (1)OncologyERBB2 (HER2)Indications and Usage, Adverse Reactions, Clinical Studies
 Tipiracil and Trifluridine (2)OncologyRASIndications and Usage, Clinical Studies
 TolazamideEndocrinologyG6PDPrecautions
 TolbutamideEndocrinologyG6PDPrecautions
 TolterodineUrologyCYP2D6Warnings and Precautions, Drug Interactions, Clinical Pharmacology
 ToremifeneOncologyESR (Hormone Receptor)Indications and Usage, Clinical Studies
 TramadolAnesthesiologyCYP2D6Boxed Warning, Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology, Patient Counseling Information
 Trametinib (1)OncologyBRAFIndications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 Trametinib (2)OncologyG6PDAdverse Reactions
 Trametinib (3)OncologyRASWarnings and Precautions
 Trastuzumab (1)OncologyERBB2 (HER2)Indications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical Studies
 Trastuzumab (2)OncologyESR, PGR (Hormone Receptor)Clinical Studies
 TretinoinOncologyPML-RARAIndications and Usage, Warnings, Clinical Pharmacology
 TriheptanoinInborn Errors of MetabolismACADVL, CPT2, HADHA, HADHB (Long-Chain Fatty Acid Oxidation Disorders)Indications and Usage, Clinical Studies
 TrimipraminePsychiatryCYP2D6Precautions
 TucatinibOncologyERBB2 (HER2)Indications and Usage, Adverse Reactions, Clinical Studies
 UmeclidiniumPulmonaryCYP2D6Clinical Pharmacology
 UpadacitinibRheumatologyCYP2D6Clinical Pharmacology
 UstekinumabDermatology and GastroenterologyIL12A, IL12B, IL23AWarnings and Precautions
 ValbenazineNeurologyCYP2D6Dosage and Administration, Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology
 Valproic Acid (1)NeurologyPOLGBoxed Warning, Contraindications, Warnings and Precautions
 Valproic Acid (2)NeurologyNonspecific (Urea Cycle Disorders)Contraindications, Warnings and Precautions
 Vemurafenib (1)OncologyBRAFIndications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies, Patient Counseling Information
 Vemurafenib (2)OncologyRASWarnings and Precautions, Adverse Reactions
 Venetoclax (1)OncologyChromosome 17pClinical Studies
 Venetoclax (2)OncologyChromosome 11qClinical Studies
 Venetoclax (3)OncologyTP53Clinical Studies
 Venetoclax (4)OncologyIDH1Clinical Studies
 Venetoclax (5)OncologyIDH2Clinical Studies
 Venetoclax (6)OncologyIGHClinical Studies
 Venetoclax (7)OncologyNPM1Clinical Studies
 Venetoclax (8)OncologyFLT3Clinical Studies
 VenlafaxinePsychiatryCYP2D6Drug Interactions, Use in Specific Populations, Clinical Pharmacology
 Viloxazine (1)PsychiatryCYP2D6Clinical Pharmacology
 Viloxazine (2)PsychiatrySLCO1B1Clinical Pharmacology
 ViltolarsenNeurologyDMDIndications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies
 VincristineOncologyBCR-ABL1 (Philadelphia chromosome)Indications and Usage, Adverse Reactions, Clinical Studies
 VoriconazoleInfectious DiseasesCYP2C19Clinical Pharmacology
 VortioxetinePsychiatryCYP2D6Dosage and Administration, Clinical Pharmacology
 VoxelotorHematologyHBBClinical Pharmacology, Clinical Studies
 VutrisiranNeurologyTTRAdverse Reactions, Clinical Pharmacology, Clinical Studies
 Warfarin (1)HematologyCYP2C9Dosage and Administration, Drug Interactions, Clinical Pharmacology
 Warfarin (2)HematologyVKORC1Dosage and Administration, Clinical Pharmacology
 Warfarin (3)HematologyPROS1Warnings and Precautions
 Warfarin (4)HematologyPROCWarnings and Precautions
 ZanubrutinibOncologyMYD88Adverse Reactions, Clinical Studies